CVS Health Corp NYSE:CVS Price, Chart, News & Insight

CVS Health Jumps 6% After Raising Full-Year Guidance on Insurance Margin Recovery

May 6, 2026 · Earnings Report

CVS Health surged 6% today after reporting first quarter 2026 results that beat expectations and prompted the company to raise its full-year earnings and cash flow guidance, with the Health Care Benefits segment delivering a dramatic improvement that reassured investors who had been watching the insurer's margin recovery closely.

Total revenues for the quarter came in at $100.4 billion, up 6.2% year-over-year, with growth across all three operating segments. GAAP diluted EPS rose to $2.30 from $1.41 in the prior year, while adjusted EPS increased to $2.57 from $2.25, beating expectations. Operating income jumped 38.7% to $4.68 billion, and adjusted operating income grew 12.5% to $5.15 billion. Cash flow from operations was $4.2 billion for the quarter.

The standout was the Health Care Benefits segment, which houses the Aetna insurance business. Adjusted operating income for the segment surged 52.6% to $3.04 billion, as the medical benefit ratio improved sharply to 84.6% from 87.3% a year ago, reflecting better underlying performance in the government business and the absence of a $448 million premium deficiency reserve recorded in the prior year. The improvement validated the company's much-discussed margin recovery plan, which had been a central concern for investors after a difficult 2025. Medical membership stood at 26.0 million as of March 31, down from 27.1 million a year ago, reflecting CVS's exit from the individual exchange business in 2026.

The Health Services segment, which includes pharmacy benefit management, posted revenues up 11.0% to $48.2 billion, though adjusted operating income dipped 7.1% to $1.49 billion due to continued pharmacy client price improvements. The Pharmacy and Consumer Wellness segment, which includes retail pharmacies, saw revenues hold roughly flat at $32.0 billion, with prescription volumes up 3.6% partly aided by the Rite Aid asset acquisitions completed in mid-2025, though adjusted operating income declined 8.8% due to reimbursement pressure and weather-related disruptions.

On the strategic front, CVS announced the launch of Health100, a health technology subsidiary that will use Google Cloud's AI technologies to deliver an integrated health care engagement platform for consumers. The company also unveiled plans for smaller pharmacy-focused retail locations and highlighted meaningful progress on prior authorization reform through Aetna, including approving more than 95% of eligible prior authorizations within 24 hours and eliminating over one million provider calls through automation.

For the full year 2026, CVS raised its GAAP diluted EPS guidance to a range of $6.24 to $6.44, up from the prior range of $5.94 to $6.14. Adjusted EPS guidance was lifted to $7.30 to $7.50 from $7.00 to $7.20, and cash flow from operations guidance was raised to at least $9.5 billion from at least $9.0 billion. The company noted it was maintaining a cautious view for the remainder of the year given continued elevated cost trends and potential macro headwinds.

💬 🔗

Global Finance News 05-06-26

CVS Health® (NYSE: CVS) will hold a conference call on Wednesday, May 6th, 2026, at 8:00 a.m. ET on first quarter 2026 financial results.

💬 🔗

Global Finance News 04-07-26

CVS Health announced that its subsidiary Omnicare has entered into an asset purchase agreement with GenieRx Holdings as part of an ongoing court-supervised sale process.

GenieRx will act as the “stalking horse bidder,” setting a baseline value for Omnicare’s assets while allowing competing bids. The deadline for alternative offers is April 30, with a potential auction scheduled for May 5, 2026.

Omnicare said it will continue operating normally during the process, maintaining pharmacy services for long-term care facilities, including skilled nursing and assisted living communities.

The company emphasized that the agreement reflects continued interest in its business and supports efforts to maximize value while ensuring uninterrupted care for patients.

💬 🔗

Global Finance News 04-03-26

CVS Health announced the opening of its first pharmacy-only CVS Pharmacy location in Chicago, marking the start of a broader rollout of smaller, dedicated pharmacy formats.

The company plans to open nearly 20 such locations in 2026, designed to improve access to medications, vaccinations, and pharmacist consultations, particularly in underserved communities.

These compact, apothecary-style stores focus on core pharmacy services with a limited retail offering, aiming to enhance patient interaction and provide more personalized care.

The initiative reflects CVS’s strategy to adapt its retail footprint and meet evolving healthcare needs, emphasizing in-person pharmacist engagement alongside digital services.

💬 🔗

WS Investor 03-30-26

CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of $0.665 cents per share on the Common Stock of the Corporation. The dividend is payable on May 4, 2026, to holders of record on April 23, 2026.

💬 🔗

Global Finance News 03-19-26

CVS Health and Google Cloud partner to develop AI-driven healthcare engagement platform

CVS Health and Google Cloud have announced a strategic partnership to develop a new AI-powered healthcare consumer engagement platform through CVS Health’s newly launched technology subsidiary, Health100.

The platform will use Google Cloud’s AI technologies, including Gemini models, Cloud Healthcare API and BigQuery, to create an integrated system that connects patients with pharmacies, healthcare providers, insurers and digital health services. The AI-native platform aims to deliver real-time, personalized health support, improve access to care and help consumers manage healthcare costs.

CVS Health said the Health100 platform is designed to provide an always-on digital health partner that can guide patients through care decisions and connect them with services such as pharmacist-led care management. The platform is expected to launch in 2026 and will allow other healthcare innovators to build applications within its ecosystem.

💬 🔗

The Investor 03-07-26

CVS Health Corporation reported solid revenue growth for the fourth quarter and full year 2025, alongside reaffirmed earnings guidance for 2026.

In the fourth quarter, total revenues rose 8.2% year-over-year to $105.7 billion. GAAP diluted EPS was $2.30, while adjusted EPS came in at $1.09.

For the full year 2025, revenues reached a record $402.1 billion, up 7.8% from the prior year. GAAP diluted EPS totaled $1.39, and adjusted EPS was $6.75. The company generated $10.6 billion in cash flow from operations during the year.

Operationally, CVS Pharmacy completed its transition to cost-based reimbursement across its Commercial, Third-Party Discount, Medicare and Medicaid businesses. Aetna improved prior authorization performance, approving more than 95% of eligible requests within 24 hours. Caremark ended 2025 with strong customer retention and new client wins, positioning the segment for momentum into 2026.

For 2026, CVS confirmed GAAP diluted EPS guidance of $5.94 to $6.14 and adjusted EPS guidance of $7.00 to $7.20. However, it lowered its cash flow from operations outlook to at least $9.0 billion, from a prior expectation of at least $10.0 billion.

CEO commentary emphasized ongoing transformation efforts across the company’s integrated health care platform, highlighting initiatives to lower drug prices, streamline care navigation and strengthen CVS’s role as a primary access point for health services in the U.S.

Source: CVS Health press release

💬 🔗

Global Finance News 02-11-26

Aetna Medicaid, part of CVS Health, announced a new collaboration with the National Association of Community Health Centers to improve blood pressure control among Medicaid members. The initiative will focus on communities in Illinois, Kentucky, Michigan and Virginia, targeting populations with high rates of hypertension. By combining Medicaid data, community health center expertise and evidence-based interventions, the partners aim to strengthen hypertension management, close care gaps and improve long-term cardiovascular outcomes for underserved populations.

Source: CVS Health press release, February 9, 2026

💬 🔗

Global Finance News 02-09-26

CVS Health announced new milestones aimed at simplifying health insurance and improving affordability, highlighting reduced prior authorization requirements, faster approvals, expanded interoperability, and broader use of bundled authorizations through its Aetna unit. The company also emphasized efforts to lower drug costs via biosimilars, rebate sharing at the pharmacy counter, and expanded access to low-cost primary and virtual care, while underscoring its nationwide community pharmacy footprint and economic impact.

Source: CVS Health company news, January 22, 2026.

💬 🔗

The Investor 01-25-26

CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Tuesday, February 10th, 2026, at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results.

💬 🔗

Global Finance News 01-18-26

NYSE:CVSFollow

NYSE:CVS